Martin Mackay - Insider Trading & Ownership

Entity
Individual
Location
Pfizer Inc Attn Corporate Secretary, 235 East 42 Nd Street, New York, NY
Summary
The estimated net worth of Martin Mackay is at least $3.93M dollars as of July 30, 2024. Martin Mackay is the Director of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. and owns shares of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) stock worth about $3.16M. Martin Mackay is the Director of SpringWorks Therapeutics, Inc. and owns shares of SpringWorks Therapeutics, Inc. (SWTX) stock worth about $384K. Martin Mackay is the Executive Chairman, Director of Rallybio Corp and owns shares of Rallybio Corp (RLYB) stock worth about $382K.
All Insider Reports
All Insider Reports

Ownership of Martin Mackay

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Director $3.16M May 13, 2024
SWTX SpringWorks Therapeutics, Inc. Director $384K Jul 29, 2024
RLYB Rallybio Corp Executive Chairman, Director $382K Feb 15, 2024

Insider Transactions Reported by Martin Mackay:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.